MedTrace Logo

A Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents

NCT02593266 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-11-20

No results posted yet for this study

Summary

The overall aim of this pilot study is to evaluate the acceptability and feasibility of an adaptation of Beardslee's 'Preventive Intervention Program (PIP) for Depression' in Chilean families.

The PIP is a family intervention directed towards strengthening family functioning and enhancing resilience in children of depressed parents. It comprises several modules that work on psycho-education and skill development within the family nucleus.

A single-blind randomized controlled trial will be conducted with two arms, the intervention arm (n=32) which will receive a home-based PIP for depression, and the TAU arm (n=32).

Conditions

Interventions

BEHAVIORAL

Preventive Intervention Program (PIP) for depression

Manualized intervention designed by Beardslee and colleagues (Beardslee et al., 2003) It is a program based on cognitive behavioural therapy, narrative therapy and systemic therapy. It is divided in 7 modules which are imparted weekly in the family home by 2 'preventionists' (therapists trained to deliver the intervention) * Module 1: Depression and family * Module 2: Psychoeducation about depression * Module 3:The child's perspective on their parent's depression * Module 4: Skills development * Module 5: Preparation for the family session * Module 6: Family session * Module 7: Revision and future planning * Follow-up

Sponsors & Collaborators

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • Wellesley College

    collaborator OTHER

  • University of Chile

    lead OTHER

Principal Investigators

  • Matias Irarrazaval, PhD · University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593266 on ClinicalTrials.gov